Form 4: Verizon Executive Kyle Malady Reports Stock Sale
SEC Form 4 Filing
EVP and Group CEO of Verizon Business, Kyle Malady, reports the sale of 7,500 shares of Verizon Communications Inc. stock at a price of $43.875 per share on April 30, 2025.
Summary
- On April 30, 2025, Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications Inc., sold 7,500 shares of common stock at $43.875 per share.
- Following the transaction, Malady directly owns 19,008 shares of Verizon common stock.
- Malady also indirectly owns 18,409 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: This is a routine disclosure of a stock sale by an executive. It doesn't inherently indicate positive or negative sentiment, but rather provides transparency into insider transactions.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders, like executives and directors, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, as insider transactions are often scrutinized for signals about the company's performance.
Key Dates
| Date | Description |
|---|---|
| 04/30/2025 | Date of stock sale transaction |
| 05/01/2025 | Date of signature on the report |
Keywords
Form 4, Verizon, Stock Sale, Kyle Malady, VZ, Executive Compensation, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.